Return to Vaccine top page

■People who have had 2nd dose of their primary COVID-19 vaccination series at least 6 months ago in principle. (*1)
■People aged 12 years and older
■People who have completed their primary vaccination (2 doses) under the Japanese Vaccination Law or vaccination equivalent to the primary series (*2) in Japan.

(*1) The vaccination interval is 6 months for healthcare workers and nursing home residents who are at high risk of severe illness. And starting in March 2022, the vaccination interval for other elderly people will be 6 months, and for those under 64 years old will be 7 months. Please note that the schedule may be accelerated depending on the municipalities. Please pay attention to the notices from your local municipal office.

(*2) People who meet the following conditions. However, this is limited to those who have received two doses of any of the vaccines approved in Japan (Pfizer, Takeda/Moderna, or AstraZeneca).
(a) Vaccinated outside Japan.
(b) Vaccinated by the COVID-19 Vaccination Program for Japanese Residents Overseas.
(c) Vaccinated by the U.S. military employees in Japan.
(d) Vaccinated in clinical trials conducted by pharmaceutical manufacturers.

ページの先頭へ戻る

You will receive a "Vaccination Voucher" for the booster shot and a "Notification of Booster Shot for COVID-19 Vaccine (3rd dose)" from your municipality when it is your turn. Reservations can be made by phone or online.

(*1) The schedule for sending out vaccination vouchers and the start of reservation acceptance may differ by municipality.
(*2) If you do not receive your voucher after 8 months from the date you completed your primary vaccination, please contact your municipality.

ページの先頭へ戻る

The period is scheduled from December 1st, 2021 to September 30th, 2022.

ページの先頭へ戻る

The third dose can be received regardless of the type of vaccine in the first or second dose as the mRNA vaccine is used regardless of the type of vaccine given for your primary vaccination. Currently, the following vaccines have received pharmaceutical approval as a COVID-19 booster dose in Japan*.
* For people aged 12 to 17, Pfizer is the only vaccination available.

-Pfizer Inc.　 ※Learn more
  Vaccine name: Comirnaty
  Pharmaceutical approval: February 14, 2021
  Vaccine type: mRNA vaccine

-Takeda Pharmaceutical Company Limited / Moderrna Inc.　※Learn more
  Vaccine name: Spikevax Intramuscular Injection (previously COVID-19 vaccine Moderna Intramuscular Injection)
  Pharmaceutical approval: May 21, 2021
  Vaccine type: mRNA vaccine

Click here for COVID-19 vaccination instruction of Pfizer and Takeda/Moderna in other languages.

ページの先頭へ戻る

ページの先頭へ戻る

• in English
• in Japanese

ページの先頭へ戻る